Q: Pure Extracts Technologies Corp. is out with some new medical technology. Question, is this stock worth watching?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good morning,
I was hoping to get your opinion on battery plays, specifically I am looking at either RMO or CBAT for a 3-5 year hold. Thanks!
I was hoping to get your opinion on battery plays, specifically I am looking at either RMO or CBAT for a 3-5 year hold. Thanks!
Q: Could you please comment on Spark Power Group's (SPG's) current balance sheet? Would you still recommend against investing here (as you did in July 2020 because of company's debt. vs. cash position?
Q: Could I please have your latest thoughts on ACKROO. Seems they have no debt and are cash flow positive if I read correctly, thanks.
Q: Can I have your comments on this stock (since your previous comments on May 24, 2019). Thank you.
Q: Can I get your opinion on this company?
Q: Can you pls give me your opinion on KWE. Thx
Q: I would like to add to your comments to a question asked by Murray early last week. IBI Group is a much smaller company compared to Stantec and WSP but adjusted EBITDA margins are higher and its growth rate is marginally higher(lower base). Its debt is also higher at 1.1 adjusted EBITDA where as Stantec is 0.8 and WSP is 0.3(would be 0.7 except for the $550 million share issue). Insiders of IBI own approximately 36%. There are 31.3 million common shares issued and there are also 6.3 million class B shares, non voting, but exchangeable for common shares on a I for I basis. Combined there are 37.5 million shares. The management partnership owns 7.2 million of the common shares and if the class B shares were converted, the insiders would own almost 36%.
IBI seems to be on the right track now and is an interesting small cap which is undervalued based on a diluted adjusted EBITDA multiple to Stantec. Similarly Stantec is undervalued compared to WSP Global.
IBI seems to be on the right track now and is an interesting small cap which is undervalued based on a diluted adjusted EBITDA multiple to Stantec. Similarly Stantec is undervalued compared to WSP Global.
- Citi Trends Inc. (CTRN)
- MEDIFAST INC (MED)
- Construction Partners Inc. (ROAD)
- Celsius Holdings Inc. (CELH)
- Magnite Inc. (MGNI)
- Mitek Systems Inc. (MITK)
Q: Hi team,
In the US small caps in the growth mode, which are your current favorites ? Any views on FTHM-Q, CTRN-Q, ROAD-Q ?
Gratefully,
J IDS
In the US small caps in the growth mode, which are your current favorites ? Any views on FTHM-Q, CTRN-Q, ROAD-Q ?
Gratefully,
J IDS
Q: Good Day,
Currently I have approximately $72 000 invested and I am working toward ensuring that my portfolio is diversified. Your portfolio analytics tool has informed me that I need more international exposure. I recently read an article about investing in small cap ETFs now in order to realize potential gains down the road. I am wondering what you would recommend for small cap ETFs?
Regards,
Ryan
Currently I have approximately $72 000 invested and I am working toward ensuring that my portfolio is diversified. Your portfolio analytics tool has informed me that I need more international exposure. I recently read an article about investing in small cap ETFs now in order to realize potential gains down the road. I am wondering what you would recommend for small cap ETFs?
Regards,
Ryan
Q: With recent upward movement, Can you see a turnaround of this once favorite 5I stock. Can you endorse a buy hold or sell.
Best Regards,
Harold
Best Regards,
Harold
Q: Last 2 days Wildbrain had big volume trade and high gain. Are there any news that caused these events ?
Q: Hello 5i,
Can provide and info on this company?
Thanks
Dave
Can provide and info on this company?
Thanks
Dave
Q: Could you please comment on SPG's current balance sheet? Would you still recommend against investing here (as you did in July 2020) because of company's debt vs. cash position?
Q: Would you buy HAI at current price ? Thanks
Q: Any idea why such a big move with this company on Friday. I own a small position and could not find any news. I’m wondering whether I should add to it or should I wait?
Thanks John
Thanks John
- Protech Home Medical Corp. (PTQ)
- Sangoma Technologies Corporation (STC)
- ProntoForms Corporation (PFM)
- Strathcona Resources Ltd. (SCR)
- Sernova Corp. (SVA)
- Profound Medical Corp. (PRN)
- Grande West Transportation Group Inc. (BUS)
- Real Matters Inc. (REAL)
- Viemed Healthcare Inc. (VMD)
- Good Natured Products Inc. (GDNP)
- Xebec Adsorption Inc. (XBC)
- Nova Leap Health Corp. (NLH)
- Vitalhub Corp. (VHI)
- WELL Health Technologies Corp. (WELL)
- Martello Technologies Group Inc. (MTLO)
- Converge Technology Solutions Corp. (CTS)
- Quisitive Technology Solutions Inc. (QUIS)
- Skylight Health Group Inc. (SHG)
- Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD)
- Adcore Inc. (ADCO)
- Docebo Inc. (DCBO)
- Greenlane Renewables Inc. (GRN)
- Premier Health of America Inc. (PHA)
- Repare Therapeutics Inc. (RPTX)
- CloudMD Software & Services Inc. (DOC)
- Palantir Technologies Inc. (PLTR)
- Nuvei Corporation Subordinate Voting Shares (NVEI)
- Wishpond Technologies Ltd. (WISH)
- Mitek Systems Inc. (MITK)
Q: First of all, thanks for the service you provide. I have found it extremely useful since becoming a member. Second, I apologize for the number of stocks covered in the question. If it is too many, please do not respond / post.
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Q: I know that you are not a fan of this company. Have you looked at it after there last quarter. To me it just looks like where we will do things in the future and how. Seems to do more than a Uber and a DoorDash. Could it be something in the future like when Amazon and Tesla and everybody told us not to touch them in there early days? Too much debt, no earnings, over valued, to much risk. What do you think?
Thanks Again
Thanks Again
Q: Morning 5i,
I bought FTG in mid 2017 at $4.55 as it was trending upwards, but then watched (and held on) as it slipped and slipped to a low of approximately $2.00 in early 2019. I then watched some more as it rose steadily through 2019 to peak at $4.21 in early January, 2020 - leading me to naively hope my loyalty might soon be rewarded - only to watch it crash mercilessly in Feb and March 2020. I think it had started that downward trajectory before COVID took hold and, at least initially, I don't think its decline was due to the pandemic.
I went through something similar with BUS, held on devotedly, and I'm now being rewarded as it has just recently exceeded my long ago purchase price and rightly or wrongly I think its future is rather bright.
My question - do you see any prospect for FTG to have the sort of resurgence that BUS has recently had (I know that apart from the rocky road they've both been treading over the past 3 or so years they have little in common, and also that FTG is significantly smaller) or would I be well advised to take my lumps and deploy the (now considerably less) money elsewhere.
Thanks, as always, for your thoughts and advice.
Peter
I bought FTG in mid 2017 at $4.55 as it was trending upwards, but then watched (and held on) as it slipped and slipped to a low of approximately $2.00 in early 2019. I then watched some more as it rose steadily through 2019 to peak at $4.21 in early January, 2020 - leading me to naively hope my loyalty might soon be rewarded - only to watch it crash mercilessly in Feb and March 2020. I think it had started that downward trajectory before COVID took hold and, at least initially, I don't think its decline was due to the pandemic.
I went through something similar with BUS, held on devotedly, and I'm now being rewarded as it has just recently exceeded my long ago purchase price and rightly or wrongly I think its future is rather bright.
My question - do you see any prospect for FTG to have the sort of resurgence that BUS has recently had (I know that apart from the rocky road they've both been treading over the past 3 or so years they have little in common, and also that FTG is significantly smaller) or would I be well advised to take my lumps and deploy the (now considerably less) money elsewhere.
Thanks, as always, for your thoughts and advice.
Peter
Q: I'd appreciate your views on Xphyto Therapeutics, a company based in B.C. but with important partnerships in Germany. They appear to have a couple of very promising irons in the fire, including a portable PCR test for Covid-19.